FIRST SUPPLEMENTAL INDENTURE Dated as of January 26, 2006Supplemental Indenture • March 20th, 2006 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
FIRST SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”) dated as of January 26, 2006 by and among IVAX CORPORATION, a Florida corporation (the “Company”), TEVA PHARMACEUTICAL INDUSTRIES LIMITED, a corporation incorporated under the laws of Israel (the “Guarantor”), and U.S. BANK NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee”),
SECOND SUPPLEMENTAL INDENTURE Dated as of January 26, 2006Supplemental Indenture • March 20th, 2006 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
SECOND SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”) dated as of January 26, 2006 by and among IVAX CORPORATION, a Florida corporation (the “Company”), TEVA PHARMACEUTICAL INDUSTRIES LIMITED, a corporation incorporated under the laws of Israel (the “Guarantor”), Ivory Acquisition Sub II, Inc., a Florida corporation and a wholly owned subsidiary of the Guarantor (“Sister Subsidiary”), and U.S. BANK NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee”),
